
"The AARDEX group is the pioneer and world leader in developing, manufacturing, and marketing MEMS®, Medication Event Monitoring System, which measures, analyzes and facilitates patients’ compliance with prescribed drug dosing regimens in clinical trials and medical practice.
The AARDEX group has a decade of experience in providing the monitors, information technology, and expertise for measuring, analyzing, and improving patient compliance and persistence with prescribed or protocol-specified ambulatory pharmacotherapy.
Its headquarters are in Switzerland but it has a R&D center in Visé, Belgium."